Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies ...
Hitachi, Ltd. has announced that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovativ...
Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...
StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...
Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca f...
CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes....
Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Bikta...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 2.86 billion yen to support 10 partnerships...
Global biotherapeutics leader CSL Behring recently announced that Japan's Ministry of Health, Labour and ...
AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...
Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...
Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...
Japanese startup Spiber has recently announced initiation of a joint research and development project using Spiber&rsquo...
Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...
Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acq...
Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and ...
Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlib...
